All have had a 100% success record in keeping their patients out of the hospital. The NIH never did a risk benefit analysis of this drug. Here are the key things you should know about fluvoxamine for COVID: It works. But even that didnt last long. The data we have today with just 2 clinical trials (RCT and confirmatory RWE) is compelling. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. So why would we wait when lives are being lost? Fluvoxamine has a systematic review and meta-analysis published in a top medical journal. This advice is now outdated. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. (The ivermectin data are trash, Feinberg told me. The effect size is huge if the drug is given early right after symptoms start. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. I have all of these on hand and I load up on vitamin D3 every day. Twenty-four years ago, . The medical community doesnt care about saving lives. Doing something is better than nothing. Three of the four outpatient trials have been reported out: all were successful. Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. Their All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. Kirsch IDeacon BJHuedo-Medina TBScoboria AMoore TJJohnson BT Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. The sooner you start, the better the outcomes. It is currently approved for treatment of depression and obsessive compulsive disorder (OCD). Di scl ai mer: T he vi ews expressed i n t hi s art i cl e are my own personal opi ni on based on my 1, 000+ hour st udy of cut t i ng edge . National Patterns in Antidepressant Medication Treatment - Home of JAMA Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals 36m "We found Fauci was the most highly compensated federal employee. Keyword: ivermectin Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanitys biggest threats. Some people are jittery, but usually that is because the doctor either prescribed a dosage higher than 50mg twice a day or didnt notify the patient to. The evidence is solid. Its whether Merck can make a killing that matters. This is the gold standard of evidence based medicine. Keeping this drug off the NIH Guidelines does nothing to reduce the death rate. He has been a medical philanthropist for more than 20 years. He pushes fluvoxamine, an anti-depression drug which despite doing very well in covid treatment studies has been strangely neglected. In November, CETF gave the group an additional $500,000 for a phase 3 clinical trial that might show conclusive proof of efficacy. But the potential upsides. The medical community did nothing (with a few exceptions like Dr. Seftel). Steve Kirsch is a Silicon Valley philanthropist. In the early days of the pandemic, as billions of dollars poured into the hunt for novel treatments and vaccines, veteran Silicon Valley entrepreneur Steve Kirsch did what hes always done: He went looking for an underdog. After one or two conversations like that, I got tired of arguing, so I started avoiding his calls.. Stopping the meds will return you to your normal self. Weve known it works since August 24, 2020. How can the FDA say a drug which meets the gold standard of evidence has insufficient evidence? We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. Always be self aware when using fluvoxamine. The FDA approved Molnupiravir which was less effective. Instead, it erodes confidence in our government to provide timely advice that is in the public interest. From the French observational data (see the very last page), it appears that the biggest effect is limiting serotonin release (any SSRI will do that). But as Kirsch has clashed with the experts he initially surrounded himself with, hes grown increasingly close to others who share his perspectives on vaccineswho have, in turn, provided a large and receptive audience to his claims about a fluvoxamine conspiracy. NIH is still unsure whether fluvoxamine should be used to treat COVID. Skirsch.io site visitors volume is 1,957 unique day-to-day guests and their 3,914 pageviews. Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: Tech millionaire Steve Kirsch went from covid trial funder to There may be a depression of libido while on drug, but since the drug is taken on acute basis, this is only temporary and it reverses once the drug is stopped. The infectious disease scientists lied to me. Some people report mild nausea while on the drug (stops when stop the drug). They immediately ruled out the vaccine, because the vaccine is, quote, safe.. Other drugs in this class include Prozac (fluoxetine), Zoloft (sertraline) and Paxil (paroxetine). See the repository above. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! I believe they made the right decision and we should be rushing to follow their advice. I disagree with his interpretation of the data regarding several medicines and strongly disagree with his anti-vaccine nonsense, Boulware wrote to me. Several former members told me he began relentlessly pressuring them to promote the drug in media stories, often during exhausting, circuitous conversations. Now weve lost the high ground, Morris told me. Steve Kirsch is looking for an explanation for 171,000 excess deaths. . Compulsive hand washing? I must admit that this is an anniversary that snuck Expert Panel Discussion on COVID-19 and Medical Freedom This suggests that a 50mg BID loading dose for day one, followed by 50mg QD dose for the following 13 days should also be quite effective. Or just depression about the vaccine mandates? CETF was founded by entrepreneur and philanthropist Steve Kirsch, as a way to expedite the fight against COVID-19. Jan 17. May 16, 2022. Hes now outlived his initial prognosis by several years. You will be wired for 24 hours if you dont heed my advice. Steve wanted to say, Look, Ive got all these famous [infectious disease] docs and researchers, and they all say give fluvoxamine a chance, Judith Feinberg, one of the former CETF advisory board members and vice chair of research at the West Virginia University School of Medicine, told me. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. Doctors who are most familiar with the drug would prescribe it to their patients. Every year, we pick the 10 technologies that matter the most right now. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. But they dont want their names used. Paper reviewing the evidence and mechanisms of action for fluvoxamine: Lenze Phase 2 RCT published Nov 12, 2020: Seftel RWE trial that confirmed the Phase 2 trial published Feb 1, 2021. Last Checked: 03/03/2023. Why not fluvoxamine? Its actually much harder to parse out a signal than if youre treating diabetes or cancer., In addition to the issues with fluvoxamine, advisors grew increasingly uncomfortable with Kirschs posts about ivermectin, which he has repeatedly claimed in blog posts and appearances in alternative media can be used together with fluvoxamine to prevent 100% of covid-19 deaths. Press - treatearly.org Please read and agree to the disclaimer before watching this video.. Steve Kirsch On COVID Early Treatment and CensorshipSteve Kirsch is an entrepreneur and . Fluvoxamine works on hospitalized patients too, but no US hospital will let you use it (sound familiar? So you can address your OCD and if you get COVID, youll can up the dose. Steve Kirsch - COVID-19 Early Treatment Fund Dosage there is 30mg once a day. I mean, he really, truly has a heart of gold, Char told me. Im taking low dosage Fluvoxamine as part of a multi-drug FLCCC protocol to alleviate some mild brain fog. This advice is now outdated. Hes very convincing. Im sorry to sound so cynical. Always be self aware when using fluvoxamine. In a recent post, discussing claims Kirsch made during a three-minute comment at an FDA public forum, Morris wrote: In spite of many pages of writing and claims of over a dozen independent analyses verifying their results, their evidence falls far short of substantiating these dramatic conclusions, including a claim that vaccines have caused >250K excess deaths in the USA.. Author Affiliations Article Information. Discover special offers, top stories, It was 25 years ago yesterday that Andrew Wakefield launched the modern iteration of the antivaccine movement.In doing so, he laid down a template that antivax quacks today still follow. They rejected the drug for insufficient evidence just like they always do for ivermectin. That receptor also helps regulate the body's . including the very promising Fluvoxamine. If it isn't fluvoxamine preventing hospitalization and long-haul COVID, then if you find what it is, you win. Ivermectin has a very high quality systematic review, the highest possible level in Evidence Based Medicine. On Dr. Drew, he told a story about a friends daughter who had to get an abortion because of damage caused by the shot. Some people report mild nausea while on the drug (stops when stop the drug). But not 150K. I have all of these on hand and I load up on vitamin D3 every day. He thinks # killed by vax could be anywhere between 0 and 150K people dead.. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. At the beginning of the COVID-19 pandemic, Steve Kirsch created the COVID-19 Early Treatment Fund (CETF) to finance trials of off-patent drugs in an attempt to find a potent treatment that had been staring us in the face. It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. TV NEWS : Search Captions. Borrow Broadcasts : TV Archive : Internet If you were drowning and we had no known standard of care to save your life and someone had a life preserver which worked 160 times in a row, should we throw them the life preserver or let them drown because we aren't absolutely sure the life preserver's benefit > risk (since just because it worked 160 times in a row and there is a 99.99% chance the effect didn't happen by chance, we could have just gotten lucky). Some countries dont have fluvoxamine so this is the alternative. So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. Doctors who have used fluvoxamine in the US and other countries swear by it. He prefers iconoclastic approaches, whether by directly funding asteroid detection or advocating for nuclear power to combat global warming. I asked to give a talk about COVID at MIT, but they couldn't find a faculty member to sponsor it. All can merit a fluvoxamine prescription based on traditional diagnoses. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. In October, the group reported that, while a few patients in the placebo group ended up in the hospital, none of the patients receiving fluvoxamine got sick enough to go. There were no studies reported out so far where fluvoxamine made things worse or neutral. For decades, coders wrote critical systems in C and C++. About 10 minutes on the internet will show you those two gentlemen, who have appeared together, have been extensively fact checked for false or misleading claims or misuse of VAERS reporting and other data. We asked Steve to tone it down. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. Where did it go wrong. The drug was FDA-approved more than 65 years ago. In every case we are aware of, the drug was successful in reversing COVID symptoms, generally in 3 days or less. 1:49 22, 2021, 9:00 a.m. Steve Kirsch , a former tech entrepreneur who earned a fortune worth up to $300 million, has been showcased on TrialSite a few times for his activity supporting the clinical development of repurposed drugs for COVID-19 treatments. Here is the latest version. Another is to identify an asteroid that is going to hit the planet.. Or just depression about the vaccine mandates? She understands complex, politicized pandemicsshe was one of the first clinicians to specialize in HIV/AIDS, and she sat on the FDA advisory panel that approved the first antiretroviral drug. When was the last time you saw a phase 3 fail where there was a 100% effect size in both an RCT and RWE study along with 4 independent observational trials all showing a positive effect, and there is clear mechanism of action where there is less than a 1% chance that it is not working (the SSRI's ordered their impact based on their Sigma activation which is 1 in 120 options), and where in every single case we are aware of the patient taking the drug reversed to normal in an average of 3 days? There were no studies reported out so far where fluvoxamine made things worse or neutral. Fluvoxamine at 50mg twice a day for 14 days is a very well-tolerated drug (as long as you avoid caffeine and alcohol) for the treatment of COVID infections. I think so. It is about following orders and making money for the drug companies and protecting the doctor from liability and losing his medical license. Medium banned him for misinformation. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. That is when the phase 2 results were published. Most doctors wont use it until NIH greenlights it, no matter what the science says. If you ask your doctor for any evidence that fluvoxamine doesnt work or is harmful (like a DB-RCT which is the only thing they trust), they will show you nothing. The NIH never did a risk benefit analysis of this drug. Part of TV News Archive. fluvoxamine - Steve Kirsch Home page As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. It has enrolled only 130 people in the first month and is enrolling only 70 per week now. 90,000 people don't have to die in the next 3 weeks. If you start 5 days after symptoms, all bets are off. This story is part of the Pandemic Technology Project, supported by The Rockefeller Foundation. Steven Todd Kirsch is an American entrepreneur. Steve Kirsch Home page All the medical journals refused to publish the meeting notes (rejected by 6 journals). just like ivermectin). Who knows, Morris replied. Seftel was able to duplicate the 100% protection from hospitalization and death in the treatment group, vs. a 12.5% hospitalization/death rate for the No treatment group. One user reported dilated pupils and increased heart rate (which could be nerves about the dilated pupils). His latest startup, M10, is a spin-off of a spin-off that sells a blockchain for banks. The race to find covid-19 drug treatments that actually work, The antimalarial drug Trump took for covid might actually be dangerous. Antidepressant fluvoxamine could keep mild COVID-19 from worsening 90,000 people will die in the next 3 weeks alone if we continue to ignore this drug that has caused no harm. Its all about NIH saying it is OK. Medicine today is driven by government opinion, not science. Steve is a Silicon Valley entrepreneur and philanthropist who founded the COVID-19 Early Treatment Fund (CETF) at the beginning of the pandemic. He has been a medical philanthropist for more than 20 years. 47).. Once the Phase 2 result came out, it should have been embraced by doctors. Doctors have no excuse for not prescribing. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. . 21. CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. Fluvoxamine data for COVID-19 Treatment - COVID-19 Early Treatment Fund Doctors who have used fluvoxamine in the US and other countries swear by it. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month . Jeffrey Glenn, an infectious disease professor at Stanford University, calls the inaction on the current evidence on the table "criminal.". Enter the email address you signed up with and we'll email you a reset link. Fluvoxamine for early treatment of covid-19 - Medical Update Online We need to keep people out of the hospital in the first place. The only way to do that is to treat them as early as possible with a drug that prevents hospitalization and death. Elsewhere he has said he began questioning vaccine safety after an unnamed Twitter follower told him several family members died after getting their shots. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. The Lancet paper showed that if you were treated early enough and took the drug as prescribed (it only works if you take it), it was shown to reduce your chance of death by 12X making it far more effective than any other drug for COVID. If you take fluvoxamine, please avoid caffeine while on the drug. This is what the Seftel trial at Golden Gate fields used. The 50mg BID dose was quite effective, but it has to be started early (as soon as symptoms start). This post was written to memorialize the corruption. By Steve Kirsch in fluvoxamine Feb 14, 2021 The case for fluvoxamine for treating COVID-19 A very short op-ed arguing for using fluvoxamine against COVID. Fluvoxamine (Luvox) is a Selective Serotonin Receptor Inhibitor (SSRI) that is clinically indicated for OCD in children, and can be used off label for depression. - Quora, Heres presentation I gave at the re-open California Conference on January 9,2021: How to fix the problemHow to fix the problem Steve Kirsch Executive DirectorCOVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008Google Docs[https://docs.google.com/presentation/d/1-A4y78wv3tTPmVu57FOabY6j-MJbPwMGojKwZfaCkAs/. Current Early Covid treatment from Steve Kirsch (infection, doctor . Links to evidence about fluvoxamine including the public data repository. I have never heard of a case it didn't work. Lack of action. He applied the drug to a large COVID outbreak at Golden Gate Fields just days after the Lenze trial was published. I also think it makes a lot of sense to look for pre-existing drugs that can help treat covid symptoms. A very short op-ed arguing for using fluvoxamine against COVID. CETF Founder Steve Kirsch discusses why we can't wait for a COVID-19 vaccine, the importance of researching existing drugs now, and our work to raise funds for outpatient trials to identify effective . The data is there in plain sight for anyone to see today. You see this with people who have a lot of money, who think that reflects their intelligence, Richman told me. ). [NIH] doesnt want any of these treatments. Steve Kirsch reported that doctors commonly say (of fluvoxamine), "This is the most powerful drug in my arsenal. So take the lowest likely effect size * 60% success rate and you are looking at an expected 45% reduction in death which is clearly better than a 0% reduction. This alone will give roughly a 50% effect size and explains why all of the the SSRIs are effective including those that do not activate the Sigma1 receptor (e.g., Paroxetine). In September, Kirsch emailed Morris asking him to estimate the maximum number of deaths caused by vaccines.